|
| | Issue Date | Title | Author(s) |
| 101 | 1-Dec-2013 | Ligand design, synthesis and biological anti-HCV evaluations for genotypes 1b and 4a of certain 4-(3- & 4-[3-(3,5-dibromo-4-hydroxyphenyl)-propylamino] phenyl) butyric acids and 3-(3,5-dibromo-4-hydroxyphenyl)-propylamino- acetamidobenzoic acid esters | Ismail, Mohamed Abdel Hamid; Mohamed, Nasser Saad; Dokla, Eman ; Khaled A M Abouzid |
| 102 | 2021 | Lipid polymer hybrid nanocarriers as a combinatory platform for different anti-SARS-CoV-2 drugs supported by computational studies | Abdel-Bar, Hend Mohamed; Abdallah, Inas A.; Fayed, Marwa A. A.; Moatasim, Yassmin; Mostafa, Ahmed; El-Behairy, Mohammed Farrag; Elimam, Hanan; Elshaier, Yaseen A. M. M.; Abouzid, Khaled |
| 103 | 2009 | Lonazolac analogues: molecular modeling, synthesis, and in vivo anti-inflammatory activity | Ismail, MAH; Lehmann, J; Abou El Ella, D.A. ; Albohy, A; Abouzid, Khaled |
| 104 | Nov-2017 | Medicinal Attributes of Thienopyrimidine Based Scaffold Targeting Tyrosine Kinases and Their Potential Anticancer Activities | Ghith, Amna; Ismail, Nasser S M; Youssef, Khairia; Abouzid, Khaled |
| 105 | 2021 | Medicinal Chemistry Strategies Towards SO2 Donors as Research Tools and Potential Therapeutics | El-Labbad, Eman M; Ji, Xingyue; Abouzid, Khaled ; Wang, Binghe |
| 106 | Jun-2014 | Molecular design and synthesis of 1,4-disubstituted piperazines as α(1)-adrenergic receptor blockers | Hussein, Mohammed M; Serya, Rabah ; Abdel Naby, Rana M; Al-Abd, Ahmed M; Saleh, Dalia O; El-Eraky, Wafaa I; Khaled A M Abouzid ; Abou El Ella, Dalal |
| 107 | 18-Sep-2015 | Molecular design and synthesis of certain new quinoline derivatives having potential anticancer activity | Ibrahim, Diaa A; Abou El Ella, Dalal ; El-Motwally, Amira M; Aly, Rasha M |
| 108 | Oct-2013 | Molecular design and synthesis of HCV inhibitors based on thiazolone scaffold | Al-Ansary, Ghada H; Ismail, Mohamed A H; Abou El Ella, Dalal ; Eid, Sameh; Abouzid, Khaled |
| 109 | Dec-2022 | Molecular design, synthesis and biological evaluation of novel 1,2,5-trisubstituted benzimidazole derivatives as cytotoxic agents endowed with ABCB1 inhibitory action to overcome multidrug resistance in cancer cells | Abdelhafiz, Abeer H A; Serya, Rabah A T; Lasheen, Deena S. ; Wang, Nessa; Sobeh, Mansour; Wink, Michael; Abouzid, Khaled |
| 110 | Mar-2013 | Molecular design, synthesis and cell based HCV replicon assay of novel benzoxazole derivatives | Ismail, M A H; Сиддик Адель Мухаммед ; Ismail, N S M; Abouzid, Khaled |
| 111 | Dec-2021 | Molecular design, synthesis and in vitro biological evaluation of thienopyrimidine-hydroxamic acids as chimeric kinase HDAC inhibitors: a challenging approach to combat cancer | Abdel-Atty, Mona M; Farag, Nahla A; Serya, Rabah A T; Abouzid, Khaled ; Mowafy, Samar |
| 112 | 2009 | Molecular Modeling Design, Synthesis and Biological Evaluation of New Imidazoline Derivatives Linked as α1-AR Antagonists and Ang II Receptor Antagonists | Mohamed A. H. Ismail; Abou El Ella, Dalal ; Khaled A. M. Abouzid; Deena S. M. Lasheen |
| 113 | 2015 | Molecular modeling design, synthesis, and anti-hyprglycemic evaluation of certain 5-(aryl-alkoxy-benzylidine)-imidazolidine-2,4-dione derivatives as potential PPAR gamma agonists | Ismail, MAH; Abouzid, Khaled ; Abdou, NS; Lahham, A; Abou El Ella, Dalal |
| 114 | 1-Mar-2008 | Molecular modeling study and synthesis of novel pyrrolo[2,3-d]pyrimidines and pyrrolotriazolopyrimidines of expected antitumor and radioprotective activities | Abou El Ella, Dalal ; Ghorab, Mostafa M.; Noaman, Eman; Heiba, Helmy I.; Khalil, Amira I. |
| 115 | Feb-2011 | Molecular modeling study and synthesis of quinazolinone-arylpiperazine derivatives as α1-adrenoreceptor antagonists | Abou-Seri, Sahar Mahmoud; Abouzid, Khaled ; Abou El Ella, Dalal |
| 116 | 2014 | Molecular modelling and synthesis of quinazoline-based compounds as potential antiproliferative agents | Yassen, Asmaa Said Ali; Elshihawy, Hosam Eldin Abd Elhamed Ahmed; Said, Mohamed Mokhtar Amin; Abouzid, Khaled |
| 117 | 2014 | Naphthalene and 2,3-dihydrobenzo[b][1,4]dioxine derivatives with extended side chains as new scaffolds of CB2-selective ligands | Osman, Noha A.; Mahmoud, Amr H.; Klein, Christian D.; Allarà, Marco; Di Marzo, Vincenzo; Khaled A M Abouzid ; Abadi, Ashraf H. |
| 118 | Oct-2022 | New fluorinated diarylureas linked to pyrrolo[2,3-d]pyrimidine scaffold as VEGFR-2 inhibitors: Molecular docking and biological evaluation | Adel, Mai; Abouzid, Khaled |
| 119 | Dec-2007 | A NEW SCAFFOLD FOR D3 DOPAMINERGIC AFFINITY CONTAINING ARYLPIPERAZINE FRAGMENT: MOLECULAR MODELING, SYNTHESIS, IN VITRO AND IN VIVO PHARMACOLOGICAL EVALUATION | Abou El Ella, Dalal ; Franziska K. U. Müller |
| 120 | Dec-2022 | Novel 1,3-diaryl pyrazole derivatives bearing methylsulfonyl moiety: Design, synthesis, molecular docking and dynamics, with dual activities as anti-inflammatory and anticancer agents through selectively targeting COX-2 | Shaker, Ahmed M M; Shahin, Mai I. ; AboulMagd, Asmaa M; Abdel Aleem, Seham A; Abdel-Rahman, Hamdy M; Abou El Ella, Dalal |
